# iRhythm to acquire VitalConnect for $287.5 million

iRhythm Holdings announced a definitive agreement to acquire VitalConnect for approximately $287.5 million ($237.5 million cash + $50 million stock). VitalConnect provides FDA-cleared wearable biosensor and cardiac monitoring technology.

- Type: Acquisition
- Announced: 2026-08-06
- Where: United States
- Value: $287.5M
- Status: announced
- Products: wearable biosensor, cardiac monitoring platform, multi-vitals monitoring
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [VitalConnect](https://endata.com/companies/93390.md) (target)
- [iRhythm Holdings](https://endata.com/companies/93399.md) (acquirer)

## Sources

- [uk.investing.com](https://uk.investing.com/news/stock-market-news/irhythm-to-acquire-vitalconnect-for-2875-million-93CH-4817451), 2026-08-06: "iRhythm Holdings Inc. announced today that it has entered into a definitive agreement to acquire VitalConnect Inc., a privately held wearable biosensor technology company, for approximately $287.5 million."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
